The Clorox Company
CLX
$138.78
$0.510.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -15.28% | 27.13% | -5.75% | -5.27% | 16.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.28% | 27.13% | -5.75% | -5.27% | 16.03% |
| Cost of Revenue | -14.80% | 13.40% | -11.73% | -6.10% | 1.83% |
| Gross Profit | -15.89% | 48.43% | 2.33% | -4.13% | 41.13% |
| SG&A Expenses | -5.47% | 11.55% | -29.83% | -1.75% | 12.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -55.56% | -300.00% | 910.00% | -183.33% | 280.00% |
| Total Operating Expenses | -12.00% | 10.98% | -6.93% | -5.45% | 5.70% |
| Operating Income | -31.18% | 313.51% | 2.33% | -4.10% | 120.78% |
| Income Before Tax | 74.26% | 510.34% | 16.03% | 82.86% | 4.62% |
| Income Tax Expenses | 7.50% | 1,750.00% | -3.57% | 122.22% | 42.86% |
| Earnings from Continuing Operations | 102.08% | 312.00% | 22.10% | 76.08% | -5.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.67% | -33.33% | 0.00% | 50.00% | 0.00% |
| Net Income | 107.53% | 350.00% | 22.73% | 75.83% | -6.06% |
| EBIT | -31.18% | 313.51% | 2.33% | -4.10% | 120.78% |
| EBITDA | -27.71% | 166.67% | 0.97% | -3.95% | 87.26% |
| EPS Basic | 108.23% | 350.54% | 22.25% | 75.94% | -6.54% |
| Normalized Basic EPS | -29.82% | 478.85% | 2.63% | -2.03% | 132.71% |
| EPS Diluted | 105.63% | 370.41% | 22.16% | 75.99% | -6.39% |
| Normalized Diluted EPS | -30.07% | 477.82% | 2.69% | -2.03% | 132.70% |
| Average Basic Shares Outstanding | -0.33% | -0.14% | 0.39% | 0.49% | 0.51% |
| Average Diluted Shares Outstanding | 0.03% | 0.02% | 0.33% | 0.49% | 0.51% |
| Dividend Per Share | 1.67% | 1.67% | 1.67% | 1.69% | 1.69% |
| Payout Ratio | -0.51% | -0.77% | -0.17% | -3.19% | 0.09% |